or Try an Advanced Search...

    Recombinant Proteins Stocks List

    Symbol Grade Name % Change
    AMGN B Amgen Inc. 0.37
    ASND C Ascendis Pharma A/S 0.06
    CHRS F Coherus BioSciences, Inc. 5.34
    MODD C Modular Medical, Inc. 3.32
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Biotechnology Medicine Diabetes Insulin Peptide Hormones Adalimumab Biopharmaceutical Biosimilar Blood Cells Bone Bone Disease Breakthrough Therapy Breast Cancer Cancer Care Chemotherapy Clinic Clinical Medicine Dialysis Disease Dow Jones Component

    Related ETFs - A few ETFs which own one or more of the above listed Recombinant Proteins stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 16.22
    BBH C Market Vectors Biotech ETF 15.08
    IBBQ C Invesco Nasdaq Biotechnology ETF 9.63
    IBB C iShares Nasdaq Biotechnology Index Fund 9.41
    BIS C ProShares UltraShort Nasdaq Biotechnology 9.07
    View all Recombinant Proteins ETFs...
    Compare ETFs
    Compare IBB to BIS Compare IBBQ to BIS Compare IBBQ to IBB

        Recombinant Proteins Stocks Recent News

        Date Stock Title
        May 2 AMGN Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment
        May 2 AMGN Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth and Challenges
        May 2 AMGN Amgen stock rallies 13% amid weight-loss drug updates, tweaked guidance
        May 2 AMGN Amgen Soars After CEO Gives Update on Experimental Obesity Drug
        May 2 AMGN Amgen, DraftKings, Live Nation: Trending tickers
        May 2 ASND Ascendis Pharma reports Q1 results
        May 2 AMGN UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22%
        May 2 AMGN Amgen Surges On Strong First-Quarter Profit As Obesity Space Heats Up
        May 2 AMGN Amgen in charts: Major drug sales grow at slower pace Y/Y, rev from Enbrel dips in Q1
        May 2 AMGN Amgen Non-GAAP EPS of $3.96 beats by $0.05, revenue of $7.45B in-line
        May 2 AMGN Amgen 'encouraged' by weight-loss drug interim data, shares jump
        May 2 AMGN AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
        May 2 ASND Ascendis Pharma Reports First Quarter 2024 Financial Results
        May 2 AMGN Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
        May 1 ASND Ascendis Pharma Q1 2024 Earnings Preview
        May 1 AMGN Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet
        May 1 CHRS Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
        May 1 AMGN Amgen Q1 Earnings Preview: Obesity treatment updates to be the focus this season
        May 1 AMGN CytomX surges on upcoming data for Amgen-partnered cancer drug
        May 1 AMGN Amgen investors await weight-loss drug data
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Biotechnology Medicine Diabetes Insulin Peptide Hormones Adalimumab Biopharmaceutical Biosimilar Blood Cells Bone Bone Disease Breakthrough Therapy Breast Cancer Cancer Care Chemotherapy Clinic Clinical Medicine Dialysis Disease Dow Jones Component
        Recombinant Proteins

        Recombinant proteins are proteins that are produced through genetic engineering. They are created by inserting a gene from one organism into another organism, such as a bacteria or yeast, which then produces the desired protein. Recombinant proteins are used in a variety of applications, including medical treatments, research, and industrial processes.

        Browse All Tags